APOTHEEK BLINDEMAN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK BLINDEMAN
Largest movements
- Stocks and contracts +€71,197
up €71,197 (+9.6%), from €744,473 to €815,670
- Tangible fixed assets -€40,182
down €40,182 (-11.6%), from €345,014 to €304,832
of which Land and buildings: -€32,137
- Receivables within one year -€36,984
down €36,984 (-19.1%), from €193,853 to €156,868
of which Trade receivables: -€42,898
- Trade debts -€112,242
down €112,242 (-14.2%), from €792,463 to €680,220
- Reserves +€81,343
up €81,343 (+82.2%), from €98,897 to €180,240
- Other debts +€22,588
up €22,588 (+195%), from €11,555 to €34,143
- Staff costs -€108,375
down €108,375 (-31.5%), from €344,513 to €236,138
- Gross operating margin -€81,029
down €81,029 (-15.7%), from €516,923 to €435,894
- Financial income +€6,059
up €6,059, from €0 to €6,059
of which Financial income: +€6,059
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,040,412 | €2,013,072 | -€27,340 | -1.3% |
| Fixed assets | 21/28 | €345,014 | €304,832 | -€40,182 | -11.6% |
| Tangible fixed assets | 22/27 | €345,014 | €304,832 | -€40,182 | -11.6% |
| Land and buildings | 22 | €332,397 | €300,260 | -€32,137 | -9.7% |
| Plant, machinery and equipment | 23 | €1,031 | €588 | -€443 | -42.9% |
| Furniture and vehicles | 24 | €11,586 | €3,984 | -€7,602 | -65.6% |
| Current assets | 29/58 | €1,695,398 | €1,708,240 | +€12,842 | +0.8% |
| Stocks and contracts in progress | 3 | €744,473 | €815,670 | +€71,197 | +9.6% |
| Stocks | 30/36 | €744,473 | €815,670 | +€71,197 | +9.6% |
| Amounts receivable within one year | 40/41 | €193,853 | €156,868 | -€36,984 | -19.1% |
| Trade receivables | 40 | €102,423 | €59,525 | -€42,898 | -41.9% |
| Other amounts receivable | 41 | €91,429 | €97,343 | +€5,914 | +6.5% |
| Current investments | 50/53 | €37,500 | €37,500 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €706,321 | €686,388 | -€19,932 | -2.8% |
| Deferred charges and accrued income | 490/1 | €13,252 | €11,814 | -€1,438 | -10.9% |
| Total equity and liabilities | 10/49 | €2,040,412 | €2,013,072 | -€27,340 | -1.3% |
| Equity | 10/15 | €1,030,000 | €1,111,343 | +€81,343 | +7.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €98,897 | €180,240 | +€81,343 | +82.2% |
| Distributable reserves | 133 | €98,897 | €180,240 | +€81,343 | +82.2% |
| Profit (loss) carried forward | 14 | €918,703 | €918,703 | +€0 | 0.0% |
| Amounts payable | 17/49 | €1,010,412 | €901,729 | -€108,682 | -10.8% |
| Amounts payable within one year | 42/48 | €1,009,433 | €900,417 | -€109,015 | -10.8% |
| Trade debts | 44 | €792,463 | €680,220 | -€112,242 | -14.2% |
| Suppliers | 440/4 | €792,463 | €680,220 | -€112,242 | -14.2% |
| Taxes, remuneration and social security | 45 | €205,415 | €186,054 | -€19,361 | -9.4% |
| Taxes | 450/3 | €166,748 | €146,921 | -€19,826 | -11.9% |
| Remuneration and social security | 454/9 | €38,667 | €39,132 | +€465 | +1.2% |
| Other amounts payable | 47/48 | €11,555 | €34,143 | +€22,588 | +195% |
| Accrued charges and deferred income | 492/3 | €979 | €1,312 | +€333 | +34.0% |
| Remuneration, social security and pensions | 62 | €344,513 | €236,138 | -€108,375 | -31.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,262 | €40,182 | -€1,080 | -2.6% |
| Other operating charges | 640/8 | €5,973 | €3,954 | -€2,019 | -33.8% |
| Gross operating margin | 9900 | €516,923 | €435,894 | -€81,029 | -15.7% |
| Operating profit (loss) | 9901 | €125,175 | €155,620 | +€30,446 | +24.3% |
| Financial income | 75/76B | €0 | €6,059 | +€6,059 | |
| Recurring financial income | 75 | €0 | €6,059 | +€6,059 | |
| Non-recurring financial income | 76B | €0 | - | = | |
| Financial charges | 65/66B | €42,091 | €41,145 | -€947 | -2.2% |
| Recurring financial charges | 65 | €42,091 | €41,145 | -€947 | -2.2% |
| Profit (loss) for the period before taxes | 9903 | €83,083 | €120,535 | +€37,451 | +45.1% |
| Income taxes | 67/77 | €14,132 | €11,192 | -€2,940 | -20.8% |
| Profit (loss) for the period | 9904 | €68,951 | €109,343 | +€40,392 | +58.6% |
| Profit (loss) for the period to be appropriated | 9905 | €68,951 | €109,343 | +€40,392 | +58.6% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.